DocuSign, Inc. reported better-than-expected third-quarter financial results, sending its shares up 14.1% to $95.43 in pre-market trading. The company’s revenue of $754.8 million surpassed the consensus estimate of $745.26 million, and its adjusted earnings per share came in at 90 cents, beating analyst estimates of 87 cents.
The strong performance was driven by DocuSign’s ability to expand its customer base and increase demand for its electronic signature solutions. The company also issued FY25 revenue guidance above estimates, indicating a strong outlook for the business.
DocuSign is not the only stock moving higher in pre-market trading. Universe Pharmaceuticals Inc. gained 196.2% after dipping 41% on Thursday, while Zhibao Technology Inc. rose 111.7% as it announced plans to partner with PICC and Munich Re to develop new medical insurance products.
However, some stocks were not as fortunate. Oriental Rise Holdings Limited shares fell 81.23% to $10.50 after surging 599% on Thursday, while Virpax Pharmaceuticals Inc. declined 21.5% to $0.3069 after losing around 5% on Thursday.
The gains and losses in the pre-market trading session reflect the volatile nature of the stock market as investors react to company announcements and earnings reports.
Source: https://www.benzinga.com/24/12/42359436/why-docusign-shares-are-trading-higher-by-around-14-here-are-20-stocks-moving-premarket